Log in

Relevant bibliographies by topics / Metastatic progression / Books

To see the other types of publications on this topic, follow the link: Metastatic progression.

Books on the topic 'Metastatic progression'

Author: Grafiati

Published: 9 March 2023

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Metastatic progression.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

1921-, Franks L. M., and Hart I, eds. Tumour progression and metastasis. Oxford University Press for the Imperial CancerResearch Fund, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Imperial Cancer Research Fund (Great Britain). Tumour progression and metastasis. Edited by Hart I and Hart Ian. Published for the Imperial Cancer Research Fund by Oxford University Press, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Károly, Lapis, Eckhardt S, and International Union Against Cancer, eds. Carcinogenesis and tumour progression. Akadémiai Kiadó, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kaiser, Hans E., and Aejaz Nasir, eds. Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response. Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6729-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

1928-, Kaiser Hans E., Nasir Aejaz, and Nasir Nelly Adriana, eds. Selected aspects of cancer progression: Metastasis, apoptosis and immune response. Springer, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

service), ScienceDirect (Online, ed. Bone cancer: Progression and therapeutic approaches. Academic, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

L, Nicolson Garth, Fidler Isaiah J. 1936-, Triton Biosciences Inc, Smith, Kline & French Laboratories., and University of California, Los Angeles., eds. Tumor progression and metastasis: Proceedings of a Triton Biosciences-Smith, Kline & French-UCLA symposium held in Keystone, Colorado, April 6-12, 1987. A.R. Liss, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Metastatic Progression and Tumour Heterogeneity. MDPI, 2020. http://dx.doi.org/10.3390/books978-3-03928-854-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Zannetti, Antonella, Gennaro Ilardi, and Wolfgang Link, eds. Tumor Microenvironment: Molecular Mechanisms and Signaling Pathways Involved in Metastatic Progression. Frontiers Media SA, 2021. http://dx.doi.org/10.3389/978-2-88971-448-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Healey, John H., and David McKeown. Orthopaedic surgery in the palliation of cancer. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656097.003.0125.

Full text

Abstract:

Metastatic spread of cancer to bone is frequent and causes pain, disability, and functional limitation. New understanding of the homing method of cancer cells to bone and the mechanism of cancer production of pain raise possible new treatment strategies. Non-surgical treatments such as chemotherapy and hormone therapy are effective in early disease. Bisphosphonates and inhibition of osteoprotegerin prevent progression of bone lesions and avoid pain, radiation, and surgery. Radiotherapy arrests disease and relieves pain in many cases. Surgery is needed when the bone is weak or fractured. It eff

APA, Harvard, Vancouver, ISO, and other styles

11

O’Brien, Tim, and Amit Patel. Kidney cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0088.

Full text

Abstract:

Despite advances in imaging techniques, many patients with renal cancer still present with locally advanced or metastatic disease. Surgical resection remains the main stay of treatment for locally advanced disease, but is technically challenging and survival remains limited. Progression free and overall survival following nephrectomy are dependent on many factors including pathological T-stage, lymph node status, and Fuhrman grade. Patients presenting with metastatic disease still have a poor prognosis and the use of multimodal therapy has yet to deliver dramatic improvements in outcomes, with

APA, Harvard, Vancouver, ISO, and other styles

12

Lasfar, Ahmed, and Karine Cohen-Solal, eds. Tumor Progression and Metastasis. IntechOpen, 2020. http://dx.doi.org/10.5772/intechopen.77832.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Mukherji, Deborah, Aurelius Omlin, Carmel Pezaro, and Johann De Bono. Novel therapies and emerging strategies for the treatment of patients with castration-resistant prostate cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0069.

Full text

Abstract:

Castration-resistant prostate cancer (CRPC) represents a final stage of this malignancy for many men and is defined as the progression of prostate cancer despite castrate levels of testosterone. CRPC may present as a rising PSA, the development of new metastases, or worsening of known metastases. Recent advances have resulted in five new treatments for CRPC: the immunotherapy sipuleucel-T; the cytotoxic cabazitaxel; the androgen biosynthesis inhibitor abiraterone acetate; the radioisotope radium-223; and the antiandrogen enzalutamide. These have all improved overall survival in randomized phas

APA, Harvard, Vancouver, ISO, and other styles

14

Montironi, Rodolfo, Liang Cheng, Antonio Lopez-Beltran, Roberta Mazzucchelli, Matteo Santoni, and Marina Scarpelli. Prostate cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0060.

Full text

Abstract:

The incidence of prostate cancer (PCa) has risen dramatically in the last years. This event may be partially explained by the employment of digital rectal examination (DRE), serum prostate-specific antigen (PSA), and transrectal ultrasonography. In developed countries, PCa is the most frequent non-skin malignancy in males. It is estimated that one in six males will be diagnosed with PCa during their lifetime, the risk of death due to metastatic PCa being 1 in 30. Multiple factors contribute to the development of PCa, as well as to its progression to an androgen-independent state: dietary facto

APA, Harvard, Vancouver, ISO, and other styles

15

Gorelik, Elizier L. Metastasis/Dissemination (Cancer Growth and Progression). Springer, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Arzumanyan, Alla. Liver Cancer: Genesis, Progression and Metastasis. IntechOpen, 2023.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Lemieux, Julie. An exploration of responsiveness to change of psychosocial, quality of life and pain measures to supportive-expressive group therapy intervention, improvement in mood and progression of disease in women with metastatic breast cancer. 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Lemieux, Julie. An exploration of responsiveness to change of psychosocial, quality of life and pain measures to supportive-expressive group therapy intervention, improvement in mood and progression of disease in women with metastatic breast cancer. 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

NICHOLSON, GL. Nicolson: Tumor Progression & Metastasis (Proc Keystone Colorado April 1987). John Wiley & Sons Inc, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Liver Cancer - Genesis, Progression and Metastasis [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.100845.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Clarke, Noel W. Metastatic disease in prostate cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0068.

Full text

Abstract:

Metastases are the predominant cause of morbidity and death from prostate cancer (CaP). The tendency for cells to migrate from the primary site, enter the vascular/lymphatic circulation, and implant/grow at secondary sites is the principal discriminator of aggressive form indolent disease. But this process is poorly understood. Cells enter the circulation in increasing number as the disease progresses, impinging on endothelial surfaces, particularly in red bone marrow where they bind and transmigrate, forming early cell colonies. This requires chemo-attractants and nutrients enabling cellular

APA, Harvard, Vancouver, ISO, and other styles

22

Merakos, Peter. Role of Proprotein Convertases in Cancer Progression and Metastasis. Morgan & Claypool Life Science Publishers, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Galluzzi, Lorenzo, and Clement Thomas. Actin Cytoskeleton in Cancer Progression and Metastasis - Part B. Elsevier Science & Technology, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Actin Cytoskeleton in Cancer Progression and Metastasis – Part C. Elsevier, 2021. http://dx.doi.org/10.1016/s1937-6448(21)x0004-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Actin Cytoskeleton in Cancer Progression and Metastasis - Part A. Elsevier, 2020. http://dx.doi.org/10.1016/s1937-6448(20)x0007-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Actin Cytoskeleton in Cancer Progression and Metastasis - Part B. Elsevier, 2020. http://dx.doi.org/10.1016/s1937-6448(20)x0008-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Galluzzi, Lorenzo, and Clement Thomas. Actin Cytoskeleton in Cancer Progression and Metastasis - Part B. Elsevier Science & Technology Books, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Metrakos, Peter, and Majid Khatib. Role of Proprotein Convertases in Cancer Progression and Metastasis. Morgan & Claypool Life Science Publishers, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Galluzzi, Lorenzo, and Clement Thomas. Actin Cytoskeleton in Cancer Progression and Metastasis - Part C. Elsevier Science & Technology Books, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Galluzzi, Lorenzo, and Clement Thomas. Actin Cytoskeleton in Cancer Progression and Metastasis - Part A. Elsevier Science & Technology Books, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Galluzzi, Lorenzo, and Clement Thomas. Actin Cytoskeleton in Cancer Progression and Metastasis - Part C. Elsevier Science & Technology, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Thomas, Clément, and Lorenzo Galluzzi. Actin Cytoskeleton in Cancer Progression and Metastasis - Part A. Elsevier Science & Technology, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Smolkova, Bozena, Julie Earl, and Agapi Kataki, eds. Genetic and Epigenetic Regulations of Tumor Progression and Metastasis. MDPI, 2023. http://dx.doi.org/10.3390/books978-3-0365-7184-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Tse, Joyce Che Yan. Functional Heterogeneity of Fibroblasts in Cancer Progression and Metastasis. 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Kaiser, Hans E., and Aejaz Nasir. Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response. Springer Netherlands, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Khatib, Abdel-Majid. Proprotein Convertases: Discovery, Characteristics, and Link to Tumor Progression and Metastasis. Morgan & Claypool Life Science Publishers, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Khatib, Abdel-Majid, and A.-Majid Khatib. Proprotein Convertases: Discovery, Characteristics, and Link to Tumor Progression and Metastasis. Morgan & Claypool Life Science Publishers, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Kaiser, H. E. Comparative Aspects of Tumor Development (Cancer Growth and Progression). Springer, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Ajithkumar, Thankamma, Ann Barrett, Helen Hatcher, and Natalie Cook. Concepts of multidisciplinary management. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199235636.003.0003.

Full text

Abstract:

Cancer prevention 18Cancer screening 22Cancer genetics 24Genetic counselling 28Principles of cancer diagnosis and management 32Principles of surgical oncology 38Radiotherapy 42Principles of systemic therapy 46Carcinogenesis is a multistep process consisting of progressive molecular and cellular changes leading to early invasive cancer and finally to distant metastasis and death. The initiation and progression of cancer usually takes years. Attempts are being made to reverse the molecular and cellular changes at an early state of cancer initiation or progression. The World Health Organization (

APA, Harvard, Vancouver, ISO, and other styles

40

Simon, M. Celeste. Diverse Effects of Hypoxia on Tumor Progression. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Simon, M. Celeste. Diverse Effects of Hypoxia on Tumor Progression. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Michelson, S. Mathematical Modeling in Tumor Growth and Progression (Invasion and Metastasis, 4-5). S Karger Pub, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Gvozdenovic, Ana. The relevance of CD44 and hyaluronan interaction in osteosarcoma progression and metastasis. 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Eisen, Tim. The patient with renal cell cancer. Edited by Giuseppe Remuzzi. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0172.

Full text

Abstract:

Renal cancer is the commonest malignancy of the kidney and worldwide, accounts for between 2% and 3% of the total cancer burden. The mainstay of curative treatment remains surgery. There have been significant advances in surgical technique, the most important ones being nephron-sparing surgery and laparoscopic nephrectomy. The medical treatment of advanced renal cell cancer has only improved markedly in the last decade with the development of antiangiogenic tyrosine-kinase inhibitors, inhibitors of mammalian target of rapamycin, and a diminished role for immunotherapy.Tyrosine-kinase inhibitor

APA, Harvard, Vancouver, ISO, and other styles

45

Diverse Effects of Hypoxia on Tumor Progression (Current Topics in Microbiology and Immunology Book 345). Springer, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Wang, Xu, Tengchuan Jin, Christopher James Pirozzi, Xueli Zhang, and Shu-Heng Jiang, eds. Inflammatory Tumor Immune Microenvironment: Molecular Mechanisms and Signaling Pathways in Cancer Progression and Metastasis. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-754-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Ganapathy, Vadivel, Maria E. Mycielska, Eric Kenneth Parkinson, and Sebastian Haferkamp, eds. Metabolite and Nutrient Transporters in Cancer-Cell Metabolism: Role in Cancer Progression and Metastasis. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-768-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Lau, Allison Nicole. Characterization of lung tumor-propagating cells reveals a role for CD24 and Yap/Taz in lung cancer progression and metastasis. 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

Lippman, Marc E., and Robert B. Dickson. Mammary Tumorigenesis and Malignant Progression: Advances in Cellular and Molecular Biology of Breast Cancer. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

50

Mammary Tumorigenesis and Malignant Progression: Advances in Cellular and Molecular Biology of Breast Cancer (Cancer Treatment and Research). Springer, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!